Anaheim, California (February 13, 2015) -- Anaheim Clinical Trials (ACT), an adult and pediatric Phase I through Phase IV clinical research center with full-service CRO capabilities announced that the company just completed a single site, 132-subject, Japanese Bridging study. The protocol required 1st and 2nd generation subjects only, and required 17 overnight stays during the Holiday Season.
“We started in November, worked every single day in December including Christmas Eve, Christmas Day, New Years Eve and New Years day, said Peter Winkle, M.D., F.A.C.G, F.A.C.P., C.P.I., Medical Director and Principal Investigator. “Although another US site was to start enrolling after the holidays, ACT had already closed enrollment!”
“ACT has again proven that we are dedicated to exceeding our goals and delighting our customers,” said Patrick McLaughlin, Executive Director.
Advantageously located in the Los Angeles area, the southern California market provides access to a very large number of healthy Japanese subjects. ACT has successfully conducted numerous Japanese Bridging studies and has over 8,000 Japanese subjects in the research database, including 1st, 2nd, and 3rd generations, as well as dedicated Japanese recruiting specialists as part of the recruiting team.
About Anaheim Clinical Trials:
Anaheim Clinical Trials (ACT) is an adult and pediatric Phase I-IV clinical research center, located in southern California (Anaheim). In addition to healthy volunteers, ACT has been particularly successful in enrolling special patient populations, such as renal- and hepatic-impaired patients, and Japanese subjects for ethno-bridging trials. Our certified Principal Investigators have the expertise and interest in a wide variety of therapeutic areas, including GI, pain, metabolic/inflammation, infectious diseases, and respiratory. ACT has been recognized by our customers for excellent quality research, timeliness, high patient enrollment, and ease of doing business. For more information, please visit our website at www.act-trials.com.
Anaheim Clinical Trials Contact
Linda Gundaker, MBA, MT(ASCP)
Executive Director of Business Development
Phone: (610) 937-2006
lgundaker@act-trials.com
Help employers find you! Check out all the jobs and post your resume.
